A Case of Suspected Cardiac Amyloidosis: A Diagnostic Challenge in a 22-Year-Old Male with Restrictive Cardiomyopathy
Keywords:
amyloidosis, cardiac amyloidosis, restrictive cardiomyopathy, heart failure, young adult, NT-proBNPAbstract
IntroductionCardiac amyloidosis (CA) is a progressive and often terminal infiltrative cardiomyopathy resulting from the extracellular deposition of misfolded protein fibrils—primarily immunoglobulin light chains (AL) or transthyretin (ATTR)—within the heart muscle. While historically perceived as a rare condition affecting the elderly, advances in non-invasive imaging have revealed CA as an underdiagnosed cause of heart failure. However, its manifestation in young adults remains exceptionally rare, presenting a significant diagnostic challenge for general practitioners. Early recognition is vital, as subtype-specific therapies can significantly alter the clinical trajectory.
Case IllustrationWe report the case of a 22-year-old male who presented with a two-week history of progressive dyspnea, orthopnea, abdominal distention, and periorbital edema. Physical examination revealed signs of systemic congestion, including ascites (shifting dullness) and decreased breath sounds in the right lung, alongside a blood pressure of 130/90 mmHg and a heart rate of 94 bpm . Laboratory findings were remarkable for a severely elevated NT-proBNP of 8177.11 pg/mL and a high hemoglobin of 18.2 g/dL . Chest radiography demonstrated cardiomegaly (CTR 63%), pulmonary edema, and bilateral pleural effusion. Electrocardiography (ECG) revealed low-voltage QRS complexes, which stood in stark contrast to the echocardiographic evidence of significant ventricular wall thickening (IV S 1.27 cm, LV PW 1.83 cm, ) and a reduced ejection fraction of 35.3% . The discordance between ECG voltage and echocardiographic mass, combined with Grade III diastolic dysfunction, strongly suggested cardiac amyloidosis.
DiscussionThe diagnostic hallmark in this case is the "voltage-to-mass" discordance, a pathognomonic red flag where amyloid fibrils insulate the myocardium, dampening electrical signals despite increased wall thickness. In a 22-year-old, the differential diagnosis includes hereditary transthyretin amyloidosis (vATTR) or immunoglobulin light chain (AL) amyloidosis, alongside mimickers like sarcoidosis or Fabry disease. The elevated NT-proBNP and high hemoglobin reflect severe hemodynamic stress and potential hemoconcentration. Management involved stabilizing heart failure using loop diuretics and transitioning to guideline-directed medical therapy (GDMT), while pursuing definitive subtyping through serum/urine immunofixation and cardiac imaging.
ConclusionThis case emphasizes that cardiac amyloidosis must be considered in young patients presenting with unexplained heart failure and restrictive physiology. Maintaining a high index of suspicion for "red flags" like ECG-echo discordance is essential to facilitate early diagnosis and initiation of life-saving, subtype-specific treatments.
References
Cardiac amyloidosis: a case review series - OAText, diakses Februari 20, 2026, https://www.oatext.com/Cardiac-amyloidosis-a-case-review-series.php
Cardiac amyloidosis: epidemiology, diagnosis and therapy, diakses Februari 20, 2026, https://www.escardio.org/communities/councils/cardiology-practice/scientific-documents-and-publications/ejournal/volume-19/cardiac-amyloidosis-epidemiology-diagnosis-and-therapy/
In vitro and in vivo disease models of cardiac amyloidosis: progress, pitfalls, and potential, diakses Februari 20, 2026, https://academic.oup.com/cardiovascres/article/121/13/1997/8245316
Cardiac Amyloidosis: Clinical Features, Pathogenesis, Diagnosis ..., diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC10823787/
Wild type transthyretin cardiac amyloidosis in a young individual: A case report - PMC, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC8084012/
Diagnosing Cardiac Amyloidosis: Challenges and Current Gaps in Detection - Ultromics, diakses Februari 20, 2026, https://www.ultromics.com/articles/diagnosing-cardiac-amyloidosis-challenges-and-gaps-in-detection
Feature | Cardiac Amyloidosis and How to Stop Missing the Diagnosis, diakses Februari 20, 2026, https://www.acc.org/Latest-in-Cardiology/Articles/2024/04/01/00/42/Feature-Cardiac-Amyloidosis-and-How-to-Stop-Missing-the-Diagnosis
ATTR vs AL Amyloidosis - Decision Point - Medscape, diakses Februari 20, 2026, https://decisionpoint.medscape.com/cardiology/viewarticle/1003194
Cardiac Amyloidosis with Discordant QRS Voltage between Frontal ..., diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC8306315/
Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells - PMC, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC5688098/
Cardiac Amyloidosis Due to Transthyretin Protein: A Review - PMC - NIH, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC11167454/
Transthyretin Amyloidosis (ATTR-CM): Types, Causes, Treatment - Cleveland Clinic, diakses Februari 20, 2026, https://my.clevelandclinic.org/health/diseases/17855-amyloidosis-attr
Hereditary ATTR Amyloidosis, diakses Februari 20, 2026, https://arci.org/about-amyloidosis/hereditary-attr-amyloidosis/
Hereditary ATTR Amyloidosis - UCL, diakses Februari 20, 2026, https://www.ucl.ac.uk/medical-sciences/sites/medical_sciences/files/hereditary_attr_amyloidosis.pdf
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta‐analysis of screening studies - PMC, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC10084346/
Restrictive Cardiomyopathy Differential Diagnoses - Medscape Reference, diakses Februari 20, 2026, https://emedicine.medscape.com/article/153062-differential
Amyloidosis: a case series and review of the literature - PMC, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC10120233/
Restrictive Cardiomyopathy | Circulation Research - American Heart Association Journals, diakses Februari 20, 2026, https://www.ahajournals.org/doi/10.1161/circresaha.117.310982
AL – Amyloidosis Foundation, diakses Februari 20, 2026, https://amyloidosis.org/al/
Hereditary Transthyretin Amyloidosis - GeneReviews® - NCBI Bookshelf - NIH, diakses Februari 20, 2026, https://www.ncbi.nlm.nih.gov/books/NBK1194/
Amyloidosis - NHS, diakses Februari 20, 2026, https://www.nhs.uk/conditions/amyloidosis/
AL Amyloidosis, diakses Februari 20, 2026, https://arci.org/about-amyloidosis/al-amyloidosis/
Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment - PubMed, diakses Februari 20, 2026, https://pubmed.ncbi.nlm.nih.gov/38095141/
New Treatments for Cardiac Amyloidosis Emerging, but Timely Diagnosis Remains Essential to Improving Outcomes - AdventHealth, diakses Februari 20, 2026, https://www.adventhealth.com/medical/adventhealthmd/blog/new-treatments-cardiac-amyloidosis-emerging-timely-diagnosis-remains-essential-improving-outcomes
Cardiac Amyloidosis: A Hidden Cause of Heart Failure Is Now Treatable, diakses Februari 20, 2026, https://www.uhhospitals.org/blog/articles/2025/11/cardiac-amyloidosis
Palladini G, Milani P. Diagnosis and Treatment of AL Amyloidosis. Drugs. 2023 Feb;83(3):203-216. doi: 10.1007/s40265-022-01830-z. Epub 2023 Jan 18. PMID: 36652193. https://pubmed.ncbi.nlm.nih.gov/36652193/
Amyloidosis - Symptoms and causes - Mayo Clinic, diakses Februari 20, 2026, https://www.mayoclinic.org/diseases-conditions/amyloidosis/symptoms-causes/syc-20353178
AL Amyloidosis (Primary Amyloidosis): Symptoms, Treatment & What it Is - Cleveland Clinic, diakses Februari 20, 2026, https://my.clevelandclinic.org/health/diseases/15718-amyloidosis-al-amyloid-light-chain
Cardiac amyloidosis: Innovations in diagnosis and treatment ..., diakses Februari 20, 2026, https://academic.oup.com/eurheartjsupp/article/27/Supplement_1/i88/8023290
New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk - ASCO Publications, diakses Februari 20, 2026, https://ascopubs.org/doi/10.1200/JCO-25-02558
High hemoglobin count Causes - Mayo Clinic, diakses Februari 20, 2026, https://www.mayoclinic.org/symptoms/high-hemoglobin-count/basics/causes/sym-20050862
High Hemoglobin Count: Causes, Testing & Treatment - Cleveland Clinic, diakses Februari 20, 2026, https://my.clevelandclinic.org/health/symptoms/17789-high-hemoglobin-count
Electrocardiographic Patterns and Arrhythmias in Cardiac Amyloidosis: From Diagnosis to Therapeutic Management—A Narrative Review - MDPI, diakses Februari 20, 2026, https://www.mdpi.com/2077-0383/13/18/5588
Why do patients with cardiac amyloidosis often have low voltage QRS (electrocardiogram) complexes? - Dr.Oracle, diakses Februari 20, 2026, https://www.droracle.ai/articles/738913/why-do-patients-with-cardiac-amyloidosis-often-have-low
What Cardiologists Should Know About Amyloidosis - PMC, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC12471172/
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC - ArTS, diakses Februari 20, 2026, https://arts.units.it/retrieve/21eedcfe-931f-48c2-97ad-9d626ff8c837/1-s2.0-S0953620523003461-main-Post_print.pdf
Heart Failure Management in Cardiac Amyloidosis: Towards a Paradigm Shift - PMC, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC12308146/
Meta-Analysis of Pharmacological Treatments in HFmrEF and HFpEF - ACC.org, diakses Februari 20, 2026, https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2024/04/02/13/07/pharmacological-treatments-in-heart
Cardiac amyloidosis: A case report and review of literature - Baishideng Publishing Group, diakses Februari 20, 2026, https://www.wjgnet.com/2307-8960/full/v7/i6/742
Proteotoxicity and Cardiac Dysfunction - PMC - NIH, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC4443853/
Hereditary transthyretin amyloidosis: a comprehensive review with a focus on peripheral neuropathy - PMC, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC10585157/
Restrictive cardiomyopathy - EPOS™, diakses Februari 20, 2026, https://epos.myesr.org/poster/esr/ecr2020/C-10216/findings%20and%20procedure%20details
Molecular Mechanisms of Cardiac Amyloidosis - PMC, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC8744761/
AL Amyloidosis Patients Continue to Benefit from HDCT/ASCT Consolidation in the Daratumumab Era - MDPI, diakses Februari 20, 2026, https://www.mdpi.com/2077-0383/15/4/1564
Cardiac Amyloidosis Echocardiographic Appearance - Brigham and Women's Hospital, diakses Februari 20, 2026, https://www.brighamandwomens.org/heart-and-vascular-center/procedures/cardiac-amyloidosis-echocardiographic-appearance
Diagnostic challenges in cardiac amyloidosis: a case report of negative initial endomyocardial biopsy, diakses Februari 20, 2026, https://e-century.us/files/ijppp/17/3/ijppp0164514.pdf
Restrictive Cardiomyopathy - StatPearls - NCBI Bookshelf - NIH, diakses Februari 20, 2026, https://www.ncbi.nlm.nih.gov/books/NBK537234/
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy, diakses Februari 20, 2026, https://www.ahajournals.org/doi/10.1161/CIR.0000000000001250
Restrictive cardiomyopathy: definition and diagnosis - SciSpace, diakses Februari 20, 2026, https://scispace.com/pdf/restrictive-cardiomyopathy-definition-and-diagnosis-3pcra7fm.pdf
Restrictive Cardiomyopathy (RCM) - DynaMedex, diakses Februari 20, 2026, https://www.dynamedex.com/condition/restrictive-cardiomyopathy-rcm
Restrictive cardiomyopathy: definition and diagnosis - PMC, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC9712030/
Incidence and effect of secondary cardiac amyloidosis on outcomes of patients with t(11;14) multiple myeloma - PMC, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC9479066/
Vitamin A: What you should know about supplements and ATTR-CM treatments, diakses Februari 20, 2026, https://mcpress.mayoclinic.org/attr-cm/vitamin-a-what-you-should-know-about-supplements-and-attr-cm-treatments/
Cardiac Amyloidosis: Evolving Diagnosis and Management: A ..., diakses Februari 20, 2026, https://www.hfsa.org/cardiac-amyloidosis-evolving-diagnosis-and-management-scientific-statement-american-heart
Cardiac amyloidosis: Innovations in diagnosis and treatment - PMC, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC11836727/
AL or ATTR Amyloidosis? Never Two Without Three | Circulation, diakses Februari 20, 2026, https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.124.072460
Cardiac Amyloidosis - European Society of Cardiology, diakses Februari 20, 2026, https://www.escardio.org/education/content-collections/focus/cardiac-amyloidosis/
Heart Failure Management in Cardiac Amyloidosis: Towards a Paradigm Shift, diakses Februari 20, 2026, https://www.researchgate.net/publication/394102459_Heart_Failure_Management_in_Cardiac_Amyloidosis_Towards_a_Paradigm_Shift
2024 update in heart failure - PubMed, diakses Februari 20, 2026, https://pubmed.ncbi.nlm.nih.gov/38806171/
2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure - ISHLT.org, diakses Februari 20, 2026, https://www.ishlt.org/docs/default-source/standards-guidelines/2024_endorsement_acc_aha_hfqualitymeasures.pdf?sfvrsn=46e21716_1
Diastolic Dysfunction Unveiling Cardiac Light-Chain Amyloidosis: A Case Report, diakses Februari 20, 2026, https://esmed.org/MRA/mra/article/view/6168
Defining a New “Mayo Stage IIIc” Ultra Poor Risk Category in Systemic AL Amyloidosis, diakses Februari 20, 2026, https://ashpublications.org/blood/article/144/Supplement%201/890/530852/Defining-a-New-Mayo-Stage-IIIc-Ultra-Poor-Risk
Downloads
Published
Issue
Section
License
Copyright (c) 2026 I Gusti Ayu Aruna Krisnadewani, Bayu Setia (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors publishing here keep copyright but grant the journal first publication rights, under a Creative Commons Attribution-NonCommercial 4.0 License. They can distribute their work non-exclusively elsewhere with an acknowledgment of its first publication in this journal. Posting the work online before and during submission for earlier and greater citation is encouraged, reflecting Open Access benefits.
